Dr Louise Emmett is the Director of Theranostics and Nuclear medicine at St Vincent’s Hospital Sydney Australia and a clinical researcher at the Garvan Institute of Medical Research. She is a Professor of Medicine (conjoint) at the University of New South Wales. She underwent her medical training at Auckland University, New Zealand, physician training in Sydney Australia and post graduate training in nuclear cardiology in Toronto, Canada. Her Doctorate of Medicine in nuclear cardiology was completed based on weight of publications in 2014. Dr Emmett has a subspecialty interest in prostate cancer and has commenced and contributed to multiple imaging and therapy trials in prostate cancer using PSMA PET and PSMA targeted therapy since 2014. This has involved being Principal Investigator (or Co-PI) on multiple prospective phase 1-3 imaging and therapy theranostics trials. Dr Emmett is focused on the clinical development of new theranostic agents, optimal combinations and functional imaging biomarkers for better personalisation of treatment choices in theranostics.
